+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis



Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis



Circulation 114(9): 936-944



The therapeutic potential of beta2-adrenergic receptor (AR) agonists in the treatment of autoimmune diseases has been reported. However, the role of these drugs in the myocardial structure-induced autoimmune process, which is thought to play a crucial role in the progression of myocarditis to subsequent complications, has not been elucidated. Experimental autoimmune myocarditis (EAM) was induced in rats by immunization with cardiac myosin. On daily administration from day 0 after immunization, the beta2-selective AR agonists formoterol or salbutamol ameliorated EAM on day 21 and increased myocardial interleukin-10/interferon-gamma mRNA levels. Propranolol, a nonselective beta-AR antagonist, aggravated EAM on day 21 and decreased mRNA levels, whereas metoprolol, a beta1-selective AR antagonist, showed no effect. These results were reflected in vivo by the proliferation of cardiac myosin-primed lymph node cells from drug-treated rats. In vitro addition of beta2-selective AR agonists inhibited the activation of cardiac myosin fragment-specific myocarditogenic T lymphocytes, and this effect was reversed by ICI118,551, a beta2-selective AR antagonist. Furthermore, treatment with 2 different beta2-selective AR agonists starting on day 14 also ameliorated EAM on day 21. beta2-AR stimulation suppressed the development of EAM by inhibiting cardiac myosin-specific T-lymphocyte activation in lymphoid organs and by shifting the imbalance in Th1/Th2 cytokine toward Th2 cytokine. Furthermore, it also ameliorated established myocardial inflammation. beta2-AR-stimulating agents may represent important immunomodulators of the cardiac myosin-induced autoimmune process and have potential as a new therapy for myocarditis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048370267

Download citation: RISBibTeXText

PMID: 16908771

DOI: 10.1161/circulationaha.105.607903


Related references

Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response. Current Medical Research and Opinion 23 Suppl 3: S29-S36, 2007

Beta-adrenergic agonists and bronchial hyperreactivity: role of beta2-adrenergic and tachykinin neurokinin-2 receptors. Journal of Allergy and Clinical Immunology 106(1 Pt 2): S104-S108, 2000

The impact of feeding beta2-adrenergic agonists on rainbow trout muscle beta2-adrenoceptors and protein synthesis. Journal of Fish Biology 65(3): 769-787, 2004

Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96(6): 1914-1922, 1997

The Adrenergic Control of Lower Esophageal Sphincter Function: Response to Beta2 Adrenergic Agonists. Experimental Biology and Medicine 148(4): 1265-1269, 1975

Live cell imaging of Gs and the beta2-adrenergic receptor demonstrates that both alphas and beta1gamma7 internalize upon stimulation and exhibit similar trafficking patterns that differ from that of the beta2-adrenergic receptor. Journal of Biological Chemistry 279(42): 44101-44112, 2004

More, more, and even more beta2-adrenergic agents for treating acute asthma in children: is the "adrenergic approach" the only way?. Pediatric Critical Care Medicine 3(2): 202-203, 2003

Steroid and beta-adrenergic receptor modifications in target organs of broiler chickens fed with a diet containing beta2-adrenergic agents. Food and Chemical Toxicology 46(6): 2239-2243, 2008

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circulation Research 97(11): 1182-1189, 2005

Abnormal beta-adrenergic responsiveness in allergic subjects II. The role of selective beta2-adrenergic hyporeactivity. Journal of Allergy and Clinical Immunology 71(1): 57-61, 1983

Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. American Journal of Physiology. Heart and Circulatory Physiology 293(1): H376-H384, 2007

Beta2-adrenergic receptor agonists. Official Gazette of the United States Patent & Trademark Office Patents 1271(2), June 10, 2003

Design and synthesis of bivalent yohimbine derivatives as potential subtype-selective beta2-adrenergic receptor agents. Abstracts of Papers American Chemical Society 217(1-2): MEDI 113, 1999

Activation Pathways of Agonists, Partial Agonists and Inverse Agonist in Beta1 and Beta2 Adrenergic Receptors. Biophysical Journal 98(3): 646a-647a, 2010

Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Journal of Molecular Recognition 22(4): 307-318, 2009